CIK 0001041024 · Non-accelerated filer<br>Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383317208
- Phone
- 8004493353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-17 | Dawson Joseph H Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2025-10-01 | Hunter Heather SVP, Chief Operating Officer | Sale 10b5-1 | −2,868 | $1.19 | $3K | 135,391 |
| 2025-10-01 | Chole Timothy SVP and CCO | Sale 10b5-1 | −2,868 | $1.19 | $3K | 125,299 |
| 2025-10-01 | Neri Jesse SVP and CFO | Sale 10b5-1 | −886 | $1.19 | $1K | 125,728 |
| 2025-10-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −6,926 | $1.19 | $8K | 330,826 |
| 2025-07-01 | Chole Timothy SVP and CCO | Sale 10b5-1 | −2,868 | $0.82 | $2K | 128,167 |
| 2025-07-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −6,926 | $0.82 | $6K | 337,752 |
| 2025-07-01 | Neri Jesse SVP and CFO | Sale 10b5-1 | −886 | $0.82 | $727 | 126,614 |
| 2025-07-01 | Chole Timothy SVP and CCO | Sale | −2,868 | $0.82 | $2K | 128,167 |
| 2025-07-01 | Neri Jesse SVP and CFO | Sale | −886 | $0.82 | $727 | 126,614 |
| 2025-07-01 | Strobeck Mark President and CEO | Sale | −6,926 | $0.82 | $6K | 337,752 |
| 2025-05-20 | Neri Jesse SVP, FINANCE AND CFO | Grant or award · Performance-based restricted stock units | +97,500 | 97,500 | ||
| 2025-05-20 | TIMMINS MEGAN C. EVP, CLO and Secretary | Grant or award · Performance-based restricted stock units | +97,500 | 97,500 | ||
| 2025-05-20 | Chole Timothy SVP, Chief Commercial Officer | Grant or award · Performance-based restricted stock units | +85,000 | 85,000 | ||
| 2025-05-20 | Strobeck Mark President and CEO | Grant or award · Performance-based restricted stock units | +352,000 | 352,000 | ||
| 2025-05-20 | Lau Joan Director | Grant or award | +50,000 | 113,111 | ||
| 2025-05-20 | COOPER JOHN G Director | Grant or award | +50,000 | 145,451 | ||
| 2025-05-20 | Nissenson Allen Director | Grant or award | +50,000 | 142,597 | ||
| 2025-05-20 | RAVICH MARK H Director | Grant or award | +50,000 | 148,831 | ||
| 2025-05-20 | Radie Robert S Director | Grant or award | +50,000 | 143,525 |
Page 2 of 8 · 153 trades